Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 11 1998
WASHINGTON, D.C. (February 11, 1998) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement after...
Jan 7 1998
(WASHINGTON, D.C., January 7, 1998)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 21 1997
WASHINGTON, D.C. (November 21, 1997) _ Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement...
Nov 10 1997
(WASHINGTON, DC, November 10, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 7 1997
(WASHINGTON, DC, October 7, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the House...
Jul 24 1997
(WASHINGTON, DC)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement in response to the...
Jul 22 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has been honored by the Public Relations Society of America (PRSA)/Richmond, VA chapter, for...
Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...


Biotechnology News

September 2, 2014

MILAN--(BUSINESS WIRE)--First world implant of the CROWN PRT bioprosthetic aortic valve was performed in Austria at the Salzburg University Clinic.

September 2, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Specialty pharmaceutical company Hatchtech today announced positive results from its two pivotal Phase 3 clinical studies evaluating...

September 2, 2014

GALWAY, Ireland--(BUSINESS WIRE)--Neuravi will introduce the Neuravi Thromboembolic Initiative during a series of workshops on “The Science of Clot” at the ESMINT...

September 2, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer...

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced...